Correction to: Cell Death and Disease https://doi.org/10.1038/s41419-023-05715-1, published online 28 March 2023
During the final figure assembly and layout process using Adobe Illustrator, an unfortunate technical error occurred. Specifically, the same data image was inadvertently duplicated and assigned to two different experimental groups in Fig. 7H. This was purely an error in the figure assembly and labeling process and does not reflect an error in the underlying experimental data or data analysis. The image currently representing group-sh-METTL3 & DDX23 in Fig. 7H is incorrect identical to the image representing group-sh-NC in Fig. 7H.
Original Figure 7
Amended Figure 7
The original article has been updated.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lin, C., Li, T., Wang, Y. et al. Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation. Cell Death Dis 17, 231 (2026). https://doi.org/10.1038/s41419-025-08135-5
Published:
Version of record:
DOI: https://doi.org/10.1038/s41419-025-08135-5
